US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Mesoblast

16.52

-0.2400-1.43%

Volume:46.41K

Turnover:766.68K

Market Cap:2.14B

PE:-37.21

High:16.63

Open:16.63

Low:16.46

Close:16.76

52wk High:21.50

52wk Low:12.66

Shares:129.69M

Float Shares:84.12M

Volume Ratio:2.42

T/O Rate:0.06%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.4440

EPS(LYR):-0.8457

ROE:-9.86%

ROA:-4.11%

PB:3.77

PE(LYR):-19.53

Loading ...

Overview Company News Filings

Press Release: Ryoncil(r) Delivers Net Revenue of Us$36m for the Fourth Quarter Ended 30 June 2026

Mesoblast posts US$115m first-year Ryoncil revenue and strengthens capital position

Mesoblast Ltd - Ryoncil Q4 Net Revenue of Us$36m and Us$115m for Full Year

THOMSON REUTERS

Analysts Offer Insights on Healthcare Companies: Ligand Pharma (LGND), Mesoblast Limited (OtherMEOBF) and Cogstate Ltd (OtherCOGZF)

Mesoblast Receives Biologics License Application Filing Number From US FDA; Shares Up 3%

MT Newswires Live

Mesoblast receives BLA filing number from FDA for rexlemestrocel-L review

Mesoblast Receives BLA Filing Number and Requests Modular Review for Rexlemestrocel-L in Patients with End-Stage Heart Failure and LVADs

Mesoblast - Requests Modular Review of Bla for Rexlemestrocel-l in End-stage Heart Failure with Lvad

THOMSON REUTERS

Mesoblast - Rexlemestrocel-l Receives Orphan Drug and Rmat Designations

THOMSON REUTERS

JPMorgan exits substantial holder position in Mesoblast

Mesoblast Accesses $50 Million Credit Line to Refinance Debt Obligations

MT Newswires Live

Mesoblast Draws $50 Million From Facility Provided by Shareholder

MT Newswires Live

Press Release: Mesoblast Draws US$50 Million from Five-year Non-dilutive Facility

Mesoblast Taps US$50m Low-Cost Facility to Retire High-Cost Debt and Fund Growth

Mesoblast Says JPMorgan Ceases to be Substantial Holder

MT Newswires Live

Mesoblast Showcases Profitable Ryoncil Launch and Expanding Cell Therapy Pipeline in June 2026 CEO Presentation

Mesoblast Says Nearly $100 Million in Revenue Generated During First Year of Ryoncil Launch; Shares Fall 5%

MT Newswires Live

Press Release: Mesoblast Reports Ryoncil(R) Net Revenues of US$30.3m and Improved Net Operating Cash Spend for the Quarter to US$4.1 Million

Mesoblast Achieves Patient Recruitment Target in Pivotal Phase 3 Trial for Chronic Low Back Pain

Mesoblast Hits Phase 3 Recruitment Milestone in Chronic Back Pain Push

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigermoments.com/stock/MESO/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MESO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MESO\",,,,,undefined,":{"symbol":"MESO","market":"US","secType":"STK","nameCN":"Mesoblast","latestPrice":16.52,"timestamp":1788271233566,"preClose":16.76,"halted":0,"volume":46410,"delay":0,"changeRate":-0.014319809069212527,"floatShares":84117900,"shares":129686277,"eps":-0.444,"marketStatus":"Trading","change":-0.24,"latestTime":"09-01 10:00:49 EDT","open":16.63,"high":16.63,"low":16.46,"amount":766679.3234100001,"amplitude":0.010143,"askPrice":16.53,"askSize":213,"bidPrice":16.49,"bidSize":23,"shortable":3,"etf":0,"ttmEps":-0.444,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1788292800000},"marketStatusCode":2,"adr":1,"adrRate":10,"listingDate":1447390800000,"exchange":"NASDAQ","adjPreClose":16.76,"preHourTrading":{"tag":"盘前","latestPrice":16.76,"preClose":16.76,"latestTime":"04:00 EDT","volume":309,"amount":5178.84,"timestamp":1788249607854,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":16.76,"preClose":16.76,"latestTime":"19:30 EDT","volume":92,"amount":1542.272,"timestamp":1788219002035,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":2.419561,"impliedVol":0.649,"impliedVolPercentile":0.4881},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MESO\",,,,,undefined,":{"symbol":"MESO","floatShares":84117900,"roa":"-4.11%","roe":"-9.86%","lyrEps":-0.84569,"volumeRatio":2.419561,"shares":129686277,"dividePrice":0,"high":16.63,"amplitude":0.010143,"preClose":16.76,"low":16.46,"week52Low":12.66,"pbRate":"3.77","psRate":"17.82","week52High":21.5,"institutionHeld":0.0339,"latestPrice":16.52,"committee":-0.805085,"eps":-0.444,"divideRate":0,"volume":46410,"delay":0,"ttmEps":-0.444,"open":16.63,"prevYearClose":18.04,"prevWeekClose":17.44,"prevMonthClose":16.76,"prevQuarterClose":13.53,"fiveDayClose":17.19,"twentyDayClose":14.8,"sixtyDayClose":13.95},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MESO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-02-26","symbol":"MESO","fiscalQuarterEnding":"2025/12","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1772082000000,"reportTimeType":"post","actualEps":null},{"date":"2025-08-28","symbol":"MESO","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756411200000,"name":null,"time":"Post-Mkt","dateTimestamp":1756353600000,"actualEps":null},{"market":"US","date":"2025-02-26","symbol":"MESO","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1740546000000,"reportTimeType":"post","actualEps":null},{"date":"2024-10-30","symbol":"MESO","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1730318400000,"name":null,"time":"Post-Mkt","dateTimestamp":1730260800000,"actualEps":null},{"market":"US","date":"2024-08-29","symbol":"MESO","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1724904000000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MESO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MESO\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":3,"updateTime":1743652800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MESO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MESO","date":"2026-08-31","current":-37.22973,"percent":0.001637,"low":-39.962095,"twenty":-19.694709,"median":-8.163493,"eighty":-4.832947,"high":-1.760343,"avg":-11.066205,"sd":7.310191,"marketCap":2194782722.91},"quantilePoints":[{"date":"2021-09-03","current":-8.348028,"twenty":-17.2465,"median":-9.141839,"eighty":-5.906396,"marketCap":824876974.32},{"date":"2021-09-10","current":-8.16771,"twenty":-17.2465,"median":-9.141839,"eighty":-5.942665,"marketCap":807059577.04},{"date":"2021-09-17","current":-7.822879,"twenty":-17.2465,"median":-9.141839,"eighty":-5.987308,"marketCap":772986467.64},{"date":"2021-09-24","current":-8.175349,"twenty":-17.2465,"median":-9.141839,"eighty":-6.023209,"marketCap":807814368.43},{"date":"2021-10-01","current":-7.783744,"twenty":-17.2465,"median":-9.141839,"eighty":-6.050751,"marketCap":769119531.1},{"date":"2021-10-08","current":-7.386162,"twenty":-17.2465,"median":-9.141839,"eighty":-6.067515,"marketCap":729834059.96},{"date":"2021-10-15","current":-7.787078,"twenty":-17.2465,"median":-9.141839,"eighty":-6.127705,"marketCap":769448926.74},{"date":"2021-10-22","current":-8.255299,"twenty":-17.2465,"median":-9.141839,"eighty":-6.153013,"marketCap":815714349.97},{"date":"2021-10-29","current":-7.824359,"twenty":-17.245349,"median":-9.140729,"eighty":-6.200698,"marketCap":773132681.43},{"date":"2021-11-05","current":-8.277829,"twenty":-17.245349,"median":-9.140729,"eighty":-6.275713,"marketCap":817940595.29},{"date":"2021-11-12","current":-8.163493,"twenty":-17.245349,"median":-9.140729,"eighty":-6.310405,"marketCap":806642949.1},{"date":"2021-11-19","current":-8.184017,"twenty":-17.245349,"median":-9.14295,"eighty":-6.376906,"marketCap":808670944.78},{"date":"2021-11-26","current":-8.115899,"twenty":-17.245349,"median":-9.14295,"eighty":-6.429742,"marketCap":786527984.91},{"date":"2021-12-03","current":-7.301071,"twenty":-17.245349,"median":-9.14295,"eighty":-6.562113,"marketCap":707561392.26},{"date":"2021-12-10","current":-8.392226,"twenty":-17.245349,"median":-9.14295,"eighty":-6.626978,"marketCap":813307428.47},{"date":"2021-12-17","current":-6.556749,"twenty":-17.245349,"median":-9.14295,"eighty":-6.639711,"marketCap":635427661.92},{"date":"2021-12-23","current":-6.69853,"twenty":-17.245349,"median":-9.14295,"eighty":-6.642158,"marketCap":649167874.45},{"date":"2021-12-31","current":-6.856135,"twenty":-17.245349,"median":-9.14295,"eighty":-6.661797,"marketCap":664441696.36},{"date":"2022-01-07","current":-6.330136,"twenty":-17.244197,"median":-9.141839,"eighty":-6.685608,"marketCap":613466174.26},{"date":"2022-01-14","current":-6.329384,"twenty":-17.244197,"median":-9.141839,"eighty":-6.685608,"marketCap":613393311.18},{"date":"2022-01-21","current":-5.701095,"twenty":-17.244197,"median":-9.141839,"eighty":-6.685608,"marketCap":552504511.13},{"date":"2022-01-28","current":-5.111939,"twenty":-17.244197,"median":-9.141839,"eighty":-6.685608,"marketCap":495408213.04},{"date":"2022-02-04","current":-5.400062,"twenty":-17.244197,"median":-9.141839,"eighty":-6.685608,"marketCap":523330798.95},{"date":"2022-02-11","current":-5.508973,"twenty":-17.244197,"median":-9.141839,"eighty":-6.685608,"marketCap":533885570.78},{"date":"2022-02-18","current":-5.390624,"twenty":-17.244197,"median":-9.141839,"eighty":-6.685608,"marketCap":522416101.06},{"date":"2022-02-25","current":-5.218408,"twenty":-17.244197,"median":-9.141839,"eighty":-6.685608,"marketCap":507046578.78},{"date":"2022-03-04","current":-5.086589,"twenty":-17.244197,"median":-9.141839,"eighty":-6.685608,"marketCap":494238468.04},{"date":"2022-03-11","current":-5.597581,"twenty":-17.244197,"median":-9.141839,"eighty":-6.65015,"marketCap":543888931.44},{"date":"2022-03-18","current":-5.942028,"twenty":-17.244197,"median":-9.141839,"eighty":-6.628319,"marketCap":577357104.68},{"date":"2022-03-25","current":-5.673532,"twenty":-17.244197,"median":-9.141839,"eighty":-6.608028,"marketCap":551268699.89},{"date":"2022-04-01","current":-5.714731,"twenty":-17.244197,"median":-9.141839,"eighty":-6.560627,"marketCap":555271886.38},{"date":"2022-04-08","current":-5.65913,"twenty":-17.244197,"median":-9.137259,"eighty":-6.477378,"marketCap":549869340.29},{"date":"2022-04-14","current":-5.674305,"twenty":-17.244197,"median":-9.097852,"eighty":-6.415736,"marketCap":551343880.86},{"date":"2022-04-22","current":-5.440371,"twenty":-17.244197,"median":-9.029914,"eighty":-6.348321,"marketCap":528613685.55},{"date":"2022-04-29","current":-5.10283,"twenty":-17.244197,"median":-8.940141,"eighty":-6.32797,"marketCap":495816493.51},{"date":"2022-05-06","current":-4.828644,"twenty":-17.244197,"median":-8.910034,"eighty":-6.2864,"marketCap":469175193.46},{"date":"2022-05-13","current":-4.674206,"twenty":-17.244197,"median":-8.84188,"eighty":-6.268346,"marketCap":454169213.31},{"date":"2022-05-20","current":-4.723622,"twenty":-17.244197,"median":-8.84188,"eighty":-6.221933,"marketCap":458970701.99},{"date":"2022-05-27","current":-4.737002,"twenty":-17.244197,"median":-8.84188,"eighty":-6.155134,"marketCap":460270785.46},{"date":"2022-06-03","current":-4.589905,"twenty":-17.244197,"median":-8.84188,"eighty":-6.141993,"marketCap":422051001.52},{"date":"2022-06-10","current":-3.885402,"twenty":-17.244197,"median":-8.84188,"eighty":-6.101247,"marketCap":357270480.65},{"date":"2022-06-17","current":-3.326322,"twenty":-17.244197,"median":-8.84188,"eighty":-6.065673,"marketCap":305861942},{"date":"2022-06-24","current":-3.41411,"twenty":-17.245349,"median":-8.857915,"eighty":-6.04967,"marketCap":313934247.29},{"date":"2022-07-01","current":-3.262423,"twenty":-17.245349,"median":-8.857915,"eighty":-6.024422,"marketCap":299986369.81},{"date":"2022-07-08","current":-4.02801,"twenty":-17.245349,"median":-8.857915,"eighty":-6.000916,"marketCap":370383594.48},{"date":"2022-07-15","current":-3.966973,"twenty":-17.245349,"median":-8.857915,"eighty":-5.951074,"marketCap":364771147.02},{"date":"2022-07-22","current":-4.668067,"twenty":-17.245349,"median":-8.857915,"eighty":-5.918534,"marketCap":429238087.46},{"date":"2022-07-29","current":-4.610708,"twenty":-17.245349,"median":-8.857915,"eighty":-5.888804,"marketCap":423963852.65},{"date":"2022-08-05","current":-4.531359,"twenty":-17.245349,"median":-8.857915,"eighty":-5.862603,"marketCap":416667470.01},{"date":"2022-08-12","current":-5.006897,"twenty":-17.245349,"median":-8.857915,"eighty":-5.841383,"marketCap":460394145.18},{"date":"2022-08-19","current":-4.730481,"twenty":-17.245349,"median":-8.857915,"eighty":-5.808957,"marketCap":434977236.83},{"date":"2022-08-26","current":-4.603716,"twenty":-17.245349,"median":-8.857915,"eighty":-5.783668,"marketCap":423320870.38},{"date":"2022-09-02","current":-4.689055,"twenty":-17.245349,"median":-8.857915,"eighty":-5.754286,"marketCap":428331098.72},{"date":"2022-09-09","current":-4.74422,"twenty":-17.245349,"median":-8.857915,"eighty":-5.741522,"marketCap":433370288.02},{"date":"2022-09-16","current":-5.022822,"twenty":-17.245349,"median":-8.857915,"eighty":-5.725498,"marketCap":458819713.33},{"date":"2022-09-23","current":-4.459503,"twenty":-17.245349,"median":-8.857915,"eighty":-5.718084,"marketCap":407362180.77},{"date":"2022-09-30","current":-4.05202,"twenty":-17.245349,"median":-8.857915,"eighty":-5.698868,"marketCap":370139856.33},{"date":"2022-10-07","current":-5.02874,"twenty":-17.245349,"median":-8.857915,"eighty":-5.673996,"marketCap":459360276.96},{"date":"2022-10-14","current":-4.997323,"twenty":-17.245349,"median":-8.857915,"eighty":-5.660693,"marketCap":456490453.44},{"date":"2022-10-21","current":-4.92643,"twenty":-17.245349,"median":-8.857915,"eighty":-5.64326,"marketCap":450014607.79},{"date":"2022-10-28","current":-4.567762,"twenty":-17.245349,"median":-8.857915,"eighty":-5.616596,"marketCap":417251365.29},{"date":"2022-11-04","current":-4.938653,"twenty":-17.245349,"median":-8.857915,"eighty":-5.603021,"marketCap":451131067.63},{"date":"2022-11-11","current":-4.935858,"twenty":-17.245349,"median":-8.857915,"eighty":-5.603021,"marketCap":450875808.13},{"date":"2022-11-18","current":-5.014425,"twenty":-17.168844,"median":-8.823942,"eighty":-5.582947,"marketCap":458052712.81},{"date":"2022-11-25","current":-5.86331,"twenty":-17.094265,"median":-8.814088,"eighty":-5.580687,"marketCap":501817266.78},{"date":"2022-12-02","current":-6.450051,"twenty":-17.041093,"median":-8.787884,"eighty":-5.580687,"marketCap":552034073.52},{"date":"2022-12-09","current":-5.534124,"twenty":-16.797492,"median":-8.750762,"eighty":-5.578026,"marketCap":473643513.2},{"date":"2022-12-16","current":-5.469981,"twenty":-16.634882,"median":-8.710469,"eighty":-5.559645,"marketCap":468153742.56},{"date":"2022-12-23","current":-5.163662,"twenty":-16.496803,"median":-8.645955,"eighty":-5.537865,"marketCap":441937112.69},{"date":"2022-12-30","current":-5.089021,"twenty":-16.380985,"median":-8.624537,"eighty":-5.525397,"marketCap":435548925.44},{"date":"2023-01-06","current":-5.271444,"twenty":-16.380985,"median":-8.624537,"eighty":-5.512496,"marketCap":451161778.68},{"date":"2023-01-13","current":-5.596665,"twenty":-16.380985,"median":-8.624537,"eighty":-5.506703,"marketCap":478996191.4},{"date":"2023-01-20","current":-5.537578,"twenty":-16.380985,"median":-8.624537,"eighty":-5.506703,"marketCap":473939163.19},{"date":"2023-01-27","current":-5.780758,"twenty":-16.380985,"median":-8.624537,"eighty":-5.506703,"marketCap":494751941.86},{"date":"2023-02-03","current":-6.262937,"twenty":-16.380985,"median":-8.624537,"eighty":-5.506703,"marketCap":536019734.68},{"date":"2023-02-10","current":-6.341292,"twenty":-16.380985,"median":-8.624537,"eighty":-5.506703,"marketCap":542725823.3},{"date":"2023-02-17","current":-5.719448,"twenty":-16.380985,"median":-8.624537,"eighty":-5.506703,"marketCap":489504634.83},{"date":"2023-02-24","current":-5.476733,"twenty":-16.380985,"median":-8.603273,"eighty":-5.505524,"marketCap":468731654.55},{"date":"2023-03-03","current":-5.407945,"twenty":-16.154038,"median":-8.577741,"eighty":-5.501139,"marketCap":454954204.13},{"date":"2023-03-10","current":-5.797611,"twenty":-16.081849,"median":-8.553716,"eighty":-5.490314,"marketCap":487735607.87},{"date":"2023-03-17","current":-5.540376,"twenty":-15.988186,"median":-8.508649,"eighty":-5.480895,"marketCap":466095156.69},{"date":"2023-03-24","current":-5.377389,"twenty":-15.792958,"median":-8.455363,"eighty":-5.474796,"marketCap":452383600.69},{"date":"2023-03-31","current":-5.548177,"twenty":-15.666846,"median":-8.428715,"eighty":-5.472167,"marketCap":466751496.68},{"date":"2023-04-06","current":-5.777123,"twenty":-15.493386,"median":-8.376347,"eighty":-5.472167,"marketCap":486012084.11},{"date":"2023-04-14","current":-5.989236,"twenty":-15.228266,"median":-8.309505,"eighty":-5.47162,"marketCap":503856483.58},{"date":"2023-04-21","current":-5.855172,"twenty":-14.801083,"median":-8.255299,"eighty":-5.47162,"marketCap":492578040.39},{"date":"2023-04-28","current":-4.986606,"twenty":-14.657685,"median":-8.216155,"eighty":-5.46337,"marketCap":419508178.81},{"date":"2023-05-05","current":-6.254866,"twenty":-14.567574,"median":-8.183408,"eighty":-5.46337,"marketCap":526203122.87},{"date":"2023-05-12","current":-7.056893,"twenty":-14.25969,"median":-8.163493,"eighty":-5.46337,"marketCap":593675275.45},{"date":"2023-05-19","current":-7.195349,"twenty":-14.054886,"median":-8.145965,"eighty":-5.46337,"marketCap":605323146.41},{"date":"2023-05-26","current":-7.022057,"twenty":-13.903097,"median":-8.134404,"eighty":-5.46337,"marketCap":571771016.33},{"date":"2023-06-02","current":-6.990022,"twenty":-13.820925,"median":-8.094403,"eighty":-5.46337,"marketCap":569162526.11},{"date":"2023-06-09","current":-6.878381,"twenty":-13.820925,"median":-8.050679,"eighty":-5.46337,"marketCap":560072171.11},{"date":"2023-06-16","current":-7.551563,"twenty":-13.820925,"median":-8.015725,"eighty":-5.46337,"marketCap":614886036},{"date":"2023-06-23","current":-7.924353,"twenty":-13.841202,"median":-7.989011,"eighty":-5.462064,"marketCap":645240438.69},{"date":"2023-06-30","current":-7.522586,"twenty":-13.841202,"median":-7.968911,"eighty":-5.462064,"marketCap":612526551.04},{"date":"2023-07-07","current":-7.465185,"twenty":-13.841202,"median":-7.926827,"eighty":-5.462064,"marketCap":607852684.78},{"date":"2023-07-14","current":-9.556217,"twenty":-13.841202,"median":-7.917179,"eighty":-5.462064,"marketCap":778114943.93},{"date":"2023-07-21","current":-9.2532,"twenty":-13.699277,"median":-7.910006,"eighty":-5.460759,"marketCap":753441776.68},{"date":"2023-07-28","current":-7.742686,"twenty":-13.438087,"median":-7.899028,"eighty":-5.460759,"marketCap":630448194.31},{"date":"2023-08-04","current":-3.07853,"twenty":-13.233127,"median":-7.853818,"eighty":-5.456828,"marketCap":250669312.4},{"date":"2023-08-11","current":-2.359106,"twenty":-12.847114,"median":-7.831479,"eighty":-5.44782,"marketCap":192090163.95},{"date":"2023-08-18","current":-2.307949,"twenty":-12.612689,"median":-7.793295,"eighty":-5.427473,"marketCap":187924739.21},{"date":"2023-08-25","current":-3.115116,"twenty":-12.441611,"median":-7.742686,"eighty":-5.40764,"marketCap":253648304.41},{"date":"2023-09-01","current":-2.959296,"twenty":-12.363486,"median":-7.671658,"eighty":-5.391223,"marketCap":242333754.61},{"date":"2023-09-07","current":-2.880504,"twenty":-12.237449,"median":-7.63427,"eighty":-5.382905,"marketCap":235881601.78},{"date":"2023-09-15","current":-2.75293,"twenty":-12.081337,"median":-7.604346,"eighty":-5.363998,"marketCap":225434681.7},{"date":"2023-09-22","current":-2.392948,"twenty":-11.954857,"median":-7.555725,"eighty":-5.353224,"marketCap":195956085.03},{"date":"2023-09-29","current":-2.485154,"twenty":-11.852581,"median":-7.522586,"eighty":-5.341685,"marketCap":203506797.28},{"date":"2023-10-06","current":-2.175801,"twenty":-11.741835,"median":-7.468627,"eighty":-5.327153,"marketCap":178174143.45},{"date":"2023-10-12","current":-2.390919,"twenty":-11.660569,"median":-7.455584,"eighty":-5.315681,"marketCap":195789975.94},{"date":"2023-10-20","current":-2.41855,"twenty":-11.554941,"median":-7.393383,"eighty":-5.3021,"marketCap":198052626.29},{"date":"2023-10-27","current":-2.286406,"twenty":-11.456048,"median":-7.386501,"eighty":-5.287928,"marketCap":187231497.29},{"date":"2023-11-03","current":-2.359072,"twenty":-11.426171,"median":-7.340884,"eighty":-5.257217,"marketCap":193182052.75},{"date":"2023-11-10","current":-2.360738,"twenty":-11.336133,"median":-7.315666,"eighty":-5.244566,"marketCap":193318507.03},{"date":"2023-11-17","current":-2.408104,"twenty":-11.272729,"median":-7.279292,"eighty":-5.216045,"marketCap":197197195.11},{"date":"2023-11-24","current":-2.509953,"twenty":-11.272729,"median":-7.247436,"eighty":-5.192345,"marketCap":205537588.74},{"date":"2023-12-01","current":-2.664819,"twenty":-11.272729,"median":-7.209879,"eighty":-5.168811,"marketCap":218219374.88},{"date":"2023-12-08","current":-1.86696,"twenty":-11.269252,"median":-7.195777,"eighty":-5.123043,"marketCap":152883469.8},{"date":"2023-12-15","current":-2.409815,"twenty":-11.269252,"median":-7.174737,"eighty":-5.090877,"marketCap":197337398.51},{"date":"2023-12-22","current":-2.481464,"twenty":-11.269252,"median":-7.158794,"eighty":-5.074967,"marketCap":203204602.53},{"date":"2023-12-29","current":-2.630538,"twenty":-11.272729,"median":-7.13957,"eighty":-5.053291,"marketCap":215412074.09},{"date":"2024-01-05","current":-2.454018,"twenty":-11.276205,"median":-7.111517,"eighty":-5.036274,"marketCap":200957107.47},{"date":"2024-01-12","current":-2.350321,"twenty":-11.276205,"median":-7.038345,"eighty":-5.022822,"marketCap":192465435.55},{"date":"2024-01-19","current":-2.439925,"twenty":-11.27867,"median":-6.997277,"eighty":-5.014102,"marketCap":199802979.59},{"date":"2024-01-26","current":-2.162363,"twenty":-11.276205,"median":-6.898946,"eighty":-4.997323,"marketCap":177073696.58},{"date":"2024-02-02","current":-2.193197,"twenty":-11.276205,"median":-6.812857,"eighty":-4.990067,"marketCap":179598728.37},{"date":"2024-02-09","current":-2.209052,"twenty":-11.276205,"median":-6.751639,"eighty":-4.95944,"marketCap":180897009.14},{"date":"2024-02-16","current":-2.298319,"twenty":-11.276205,"median":-6.714054,"eighty":-4.945204,"marketCap":188207073.6},{"date":"2024-02-23","current":-2.351033,"twenty":-11.276205,"median":-6.705554,"eighty":-4.938653,"marketCap":192523751.14},{"date":"2024-03-01","current":-2.664789,"twenty":-11.272729,"median":-6.69853,"eighty":-4.890239,"marketCap":194684140.6},{"date":"2024-03-08","current":-2.898034,"twenty":-11.272729,"median":-6.69853,"eighty":-4.868046,"marketCap":211724592.66},{"date":"2024-03-15","current":-3.248824,"twenty":-11.272729,"median":-6.69853,"eighty":-4.857044,"marketCap":237352591.25},{"date":"2024-03-22","current":-3.426599,"twenty":-11.272729,"median":-6.69853,"eighty":-4.839224,"marketCap":250340473.19},{"date":"2024-03-28","current":-5.651155,"twenty":-11.272729,"median":-6.69853,"eighty":-4.831114,"marketCap":412862079.99},{"date":"2024-04-05","current":-8.931781,"twenty":-11.276205,"median":-6.726848,"eighty":-4.829281,"marketCap":652538079.26},{"date":"2024-04-12","current":-8.73907,"twenty":-11.276205,"median":-6.785348,"eighty":-4.829281,"marketCap":638458919.78},{"date":"2024-04-19","current":-7.695336,"twenty":-11.276205,"median":-6.867258,"eighty":-4.829281,"marketCap":562205889.63},{"date":"2024-04-26","current":-9.449433,"twenty":-11.272729,"median":-6.992619,"eighty":-4.831114,"marketCap":690356657.99},{"date":"2024-05-03","current":-11.087079,"twenty":-11.272729,"median":-7.031544,"eighty":-4.831114,"marketCap":809999812.26},{"date":"2024-05-10","current":-10.99273,"twenty":-11.336133,"median":-7.070547,"eighty":-4.831114,"marketCap":803106838.25},{"date":"2024-05-17","current":-11.31732,"twenty":-11.338315,"median":-7.13957,"eighty":-4.831114,"marketCap":826820721.82},{"date":"2024-05-24","current":-12.157853,"twenty":-11.412713,"median":-7.166404,"eighty":-4.831114,"marketCap":888228404.32},{"date":"2024-05-31","current":-11.522689,"twenty":-11.448255,"median":-7.175489,"eighty":-4.831114,"marketCap":841824657.1},{"date":"2024-06-07","current":-10.873952,"twenty":-11.456983,"median":-7.196205,"eighty":-4.831114,"marketCap":794429166.67},{"date":"2024-06-14","current":-11.201588,"twenty":-11.456983,"median":-7.212852,"eighty":-4.831114,"marketCap":818365651.02},{"date":"2024-06-21","current":-10.658738,"twenty":-11.474525,"median":-7.247845,"eighty":-4.829281,"marketCap":778706058.45},{"date":"2024-06-28","current":-10.274263,"twenty":-11.485928,"median":-7.272169,"eighty":-4.828771,"marketCap":750617059.53},{"date":"2024-07-05","current":-11.612781,"twenty":-11.506495,"median":-7.302978,"eighty":-4.828771,"marketCap":848406578.31},{"date":"2024-07-12","current":-12.58396,"twenty":-11.540364,"median":-7.327198,"eighty":-4.828771,"marketCap":919358950.04},{"date":"2024-07-15","current":-12.334621,"twenty":-11.552324,"median":-7.337552,"eighty":-4.828771,"marketCap":901142747.73},{"date":"2024-08-02","current":-9.878349,"twenty":-11.60696,"median":-7.390625,"eighty":-4.802814,"marketCap":721692401.07},{"date":"2024-08-09","current":-9.751596,"twenty":-11.60696,"median":-7.446438,"eighty":-4.802814,"marketCap":712432087},{"date":"2024-08-16","current":-10.457506,"twenty":-11.60696,"median":-7.485787,"eighty":-4.802814,"marketCap":764004522.44},{"date":"2024-08-23","current":-10.166666,"twenty":-11.60696,"median":-7.522586,"eighty":-4.802814,"marketCap":742756289.59},{"date":"2024-08-30","current":-9.075988,"twenty":-11.60696,"median":-7.555725,"eighty":-4.802814,"marketCap":798287570.12},{"date":"2024-09-06","current":-8.239151,"twenty":-11.60696,"median":-7.612842,"eighty":-4.802814,"marketCap":724682800.7},{"date":"2024-09-13","current":-8.166474,"twenty":-11.60696,"median":-7.636285,"eighty":-4.802814,"marketCap":718290417.14},{"date":"2024-09-20","current":-9.143643,"twenty":-11.60696,"median":-7.670022,"eighty":-4.802814,"marketCap":804238205.9},{"date":"2024-09-27","current":-10.058593,"twenty":-11.60696,"median":-7.701654,"eighty":-4.802814,"marketCap":884713590.13},{"date":"2024-10-04","current":-13.233592,"twenty":-11.629772,"median":-7.710373,"eighty":-4.802814,"marketCap":1163973854.47},{"date":"2024-10-11","current":-12.655691,"twenty":-11.682947,"median":-7.783744,"eighty":-4.802814,"marketCap":1113143922.37},{"date":"2024-10-18","current":-12.614959,"twenty":-11.742455,"median":-7.819962,"eighty":-4.802814,"marketCap":1109561321.58},{"date":"2024-10-25","current":-10.88576,"twenty":-11.757336,"median":-7.84048,"eighty":-4.802814,"marketCap":957467920.81},{"date":"2024-10-31","current":-11.235359,"twenty":-11.757336,"median":-7.874583,"eighty":-4.802814,"marketCap":988217264.5},{"date":"2024-11-08","current":-12.070097,"twenty":-11.784852,"median":-7.965345,"eighty":-4.802095,"marketCap":1061637429.31},{"date":"2024-11-15","current":-13.2116,"twenty":-11.864941,"median":-7.981063,"eighty":-4.802095,"marketCap":1162039497.37},{"date":"2024-11-22","current":-12.715753,"twenty":-11.937479,"median":-8.01495,"eighty":-4.802095,"marketCap":1118426790.39},{"date":"2024-11-29","current":-14.925583,"twenty":-11.99311,"median":-8.030112,"eighty":-4.802095,"marketCap":1312794529.8},{"date":"2024-12-06","current":-13.869111,"twenty":-12.081059,"median":-8.030112,"eighty":-4.802095,"marketCap":1219871481},{"date":"2024-12-13","current":-15.238561,"twenty":-12.155278,"median":-8.030112,"eighty":-4.802095,"marketCap":1340322862.07},{"date":"2024-12-20","current":-19.655608,"twenty":-12.23132,"median":-8.030112,"eighty":-4.802095,"marketCap":1728828625.98},{"date":"2024-12-27","current":-22.849807,"twenty":-12.326174,"median":-8.030112,"eighty":-4.802095,"marketCap":2009777614.81},{"date":"2025-01-03","current":-25.510876,"twenty":-12.411203,"median":-8.030112,"eighty":-4.802095,"marketCap":2243834669.73},{"date":"2025-01-10","current":-22.570346,"twenty":-12.466025,"median":-8.015725,"eighty":-4.801375,"marketCap":1985197351.74},{"date":"2025-01-17","current":-22.179282,"twenty":-12.549792,"median":-8.015725,"eighty":-4.801375,"marketCap":1950800922.38},{"date":"2025-01-24","current":-25.888933,"twenty":-12.578823,"median":-8.015725,"eighty":-4.801375,"marketCap":2277087018.9},{"date":"2025-01-31","current":-28.533871,"twenty":-12.578823,"median":-8.015725,"eighty":-4.801375,"marketCap":2509725191.7},{"date":"2025-02-07","current":-28.40223,"twenty":-12.578823,"median":-8.015725,"eighty":-4.801375,"marketCap":2498146561.09},{"date":"2025-02-14","current":-25.473382,"twenty":-12.578823,"median":-8.015725,"eighty":-4.801375,"marketCap":2240536825.03},{"date":"2025-02-21","current":-24.552429,"twenty":-12.578823,"median":-8.015725,"eighty":-4.801375,"marketCap":2159533462.25},{"date":"2025-02-28","current":-19.36097,"twenty":-12.651932,"median":-8.015725,"eighty":-4.801375,"marketCap":2000975612.73},{"date":"2025-03-07","current":-16.329051,"twenty":-12.842677,"median":-8.01495,"eighty":-4.800656,"marketCap":1687623714.29},{"date":"2025-03-14","current":-15.98864,"twenty":-13.206567,"median":-8.044734,"eighty":-4.800656,"marketCap":1652441943.89},{"date":"2025-03-21","current":-17.32566,"twenty":-13.341088,"median":-8.065625,"eighty":-4.828644,"marketCap":1790624281.49},{"date":"2025-03-28","current":-15.661493,"twenty":-13.952659,"median":-8.10617,"eighty":-4.838446,"marketCap":1618630988.07},{"date":"2025-04-04","current":-13.788825,"twenty":-14.355873,"median":-8.136207,"eighty":-4.838446,"marketCap":1425088855.62},{"date":"2025-04-11","current":-12.028409,"twenty":-14.341809,"median":-8.147572,"eighty":-4.839224,"marketCap":1243148071.47},{"date":"2025-04-17","current":-12.935635,"twenty":-14.341809,"median":-8.147572,"eighty":-4.839224,"marketCap":1336910851.09},{"date":"2025-04-25","current":-14.150386,"twenty":-14.355873,"median":-8.146769,"eighty":-4.838446,"marketCap":1462456545.77},{"date":"2025-05-02","current":-14.563747,"twenty":-14.192636,"median":-8.146769,"eighty":-4.838446,"marketCap":1505177873.02},{"date":"2025-05-09","current":-13.519085,"twenty":-14.150386,"median":-8.146769,"eighty":-4.838446,"marketCap":1397210945.08},{"date":"2025-05-16","current":-13.671698,"twenty":-13.952659,"median":-8.146769,"eighty":-4.838446,"marketCap":1412983732.57},{"date":"2025-05-23","current":-13.516483,"twenty":-13.836248,"median":-8.146769,"eighty":-4.838446,"marketCap":1396942061.07},{"date":"2025-05-30","current":-13.539379,"twenty":-13.671698,"median":-8.146769,"eighty":-4.838446,"marketCap":1399308359.86},{"date":"2025-06-06","current":-14.149764,"twenty":-13.583651,"median":-8.146769,"eighty":-4.838446,"marketCap":1462392316.68},{"date":"2025-06-13","current":-14.464717,"twenty":-13.583651,"median":-8.146769,"eighty":-4.838446,"marketCap":1494942953.83},{"date":"2025-06-20","current":-13.080063,"twenty":-13.523144,"median":-8.145965,"eighty":-4.836613,"marketCap":1351837641.17},{"date":"2025-06-27","current":-13.345861,"twenty":-13.409123,"median":-8.145965,"eighty":-4.836613,"marketCap":1379308081.68},{"date":"2025-07-03","current":-13.115128,"twenty":-13.399806,"median":-8.145965,"eighty":-4.836613,"marketCap":1355461586.94},{"date":"2025-07-11","current":-13.424082,"twenty":-13.332018,"median":-8.145965,"eighty":-4.836613,"marketCap":1387392370.04},{"date":"2025-07-18","current":-19.341572,"twenty":-13.332018,"median":-8.145965,"eighty":-4.836613,"marketCap":1998970842.14},{"date":"2025-07-25","current":-20.609176,"twenty":-13.332018,"median":-8.145965,"eighty":-4.836613,"marketCap":2129978988.57},{"date":"2025-08-01","current":-18.707228,"twenty":-13.332018,"median":-8.145965,"eighty":-4.836613,"marketCap":1933410756.22},{"date":"2025-08-08","current":-18.586009,"twenty":-13.332018,"median":-8.145965,"eighty":-4.836613,"marketCap":1920882682.96},{"date":"2025-08-15","current":-20.174209,"twenty":-13.332018,"median":-8.145965,"eighty":-4.836613,"marketCap":2085024640.96},{"date":"2025-08-22","current":-18.921709,"twenty":-13.332018,"median":-8.145965,"eighty":-4.836613,"marketCap":1955577544.79},{"date":"2025-08-29","current":-17.825409,"twenty":-13.332018,"median":-8.145965,"eighty":-4.836613,"marketCap":1820722909.62},{"date":"2025-09-05","current":-17.285173,"twenty":-13.307105,"median":-8.145372,"eighty":-4.83478,"marketCap":1765542176.46},{"date":"2025-09-12","current":-18.42662,"twenty":-13.332018,"median":-8.145965,"eighty":-4.836613,"marketCap":1882131813.83},{"date":"2025-09-19","current":-19.981179,"twenty":-13.332018,"median":-8.145965,"eighty":-4.836613,"marketCap":2040917601.56},{"date":"2025-09-26","current":-19.68854,"twenty":-13.332018,"median":-8.145965,"eighty":-4.836613,"marketCap":2011026851.06},{"date":"2025-10-03","current":-22.773018,"twenty":-13.332018,"median":-8.145965,"eighty":-4.836613,"marketCap":2326081544.74},{"date":"2025-10-10","current":-23.728478,"twenty":-13.332018,"median":-8.145965,"eighty":-4.836613,"marketCap":2423674201.28},{"date":"2025-10-17","current":-21.338263,"twenty":-13.332018,"median":-8.145965,"eighty":-4.836613,"marketCap":2179532802.55},{"date":"2025-10-24","current":-20.967839,"twenty":-13.332018,"median":-8.145965,"eighty":-4.836613,"marketCap":2141697005.01},{"date":"2025-10-31","current":-20.660836,"twenty":-13.332018,"median":-8.145965,"eighty":-4.836613,"marketCap":2110339040.57},{"date":"2025-11-07","current":-18.025651,"twenty":-13.332018,"median":-8.145965,"eighty":-4.836613,"marketCap":1841176062.45},{"date":"2025-11-14","current":-18.276122,"twenty":-13.332018,"median":-8.145965,"eighty":-4.836613,"marketCap":1866759684.73},{"date":"2025-11-21","current":-18.76734,"twenty":-13.332018,"median":-8.145965,"eighty":-4.836613,"marketCap":1916933624.19},{"date":"2025-11-28","current":-22.235713,"twenty":-13.332018,"median":-8.145965,"eighty":-4.836613,"marketCap":2271200223.41},{"date":"2025-12-05","current":-22.117314,"twenty":-13.332018,"median":-8.145965,"eighty":-4.836613,"marketCap":2259106687.41},{"date":"2025-12-12","current":-23.191606,"twenty":-13.332018,"median":-8.145965,"eighty":-4.836613,"marketCap":2368837081.72},{"date":"2025-12-19","current":-24.205623,"twenty":-13.341465,"median":-8.145965,"eighty":-4.836613,"marketCap":2472410769.54},{"date":"2025-12-26","current":-24.40692,"twenty":-13.408826,"median":-8.145965,"eighty":-4.836613,"marketCap":2492971665.77},{"date":"2026-01-02","current":-23.214818,"twenty":-13.461548,"median":-8.145965,"eighty":-4.836613,"marketCap":2371207973.58},{"date":"2026-01-09","current":-25.794461,"twenty":-13.564038,"median":-8.145965,"eighty":-4.836613,"marketCap":2634697858.72},{"date":"2026-01-16","current":-22.384404,"twenty":-13.715077,"median":-8.145965,"eighty":-4.836613,"marketCap":2286387725.44},{"date":"2026-01-23","current":-23.14756,"twenty":-13.842821,"median":-8.145965,"eighty":-4.836613,"marketCap":2364338088.99},{"date":"2026-01-30","current":-22.371873,"twenty":-13.953506,"median":-8.145965,"eighty":-4.836613,"marketCap":2285107821.71},{"date":"2026-02-06","current":-19.628431,"twenty":-14.150386,"median":-8.145965,"eighty":-4.836613,"marketCap":2004887266.84},{"date":"2026-02-13","current":-21.333587,"twenty":-14.190059,"median":-8.145965,"eighty":-4.836613,"marketCap":2179055269.54},{"date":"2026-02-20","current":-21.489699,"twenty":-14.301157,"median":-8.145965,"eighty":-4.836613,"marketCap":2195000855.91},{"date":"2026-02-27","current":-21.752341,"twenty":-14.491969,"median":-8.145965,"eighty":-4.836613,"marketCap":2052768439.47},{"date":"2026-03-06","current":-21.973066,"twenty":-14.652,"median":-8.145965,"eighty":-4.836613,"marketCap":2073598194.45},{"date":"2026-03-13","current":-20.469582,"twenty":-14.911457,"median":-8.145965,"eighty":-4.836613,"marketCap":1931714499.61},{"date":"2026-03-20","current":-19.85972,"twenty":-15.021134,"median":-8.145965,"eighty":-4.836613,"marketCap":1874161791.28},{"date":"2026-03-27","current":-19.916266,"twenty":-15.291687,"median":-8.145965,"eighty":-4.836613,"marketCap":1879498073.25},{"date":"2026-04-02","current":-20.122543,"twenty":-15.883166,"median":-8.145965,"eighty":-4.836613,"marketCap":1898964414.53},{"date":"2026-04-10","current":-20.503915,"twenty":-16.030995,"median":-8.145965,"eighty":-4.836613,"marketCap":1934954477.06},{"date":"2026-04-17","current":-22.081334,"twenty":-16.352631,"median":-8.145965,"eighty":-4.836613,"marketCap":2083815414.28},{"date":"2026-04-24","current":-21.537744,"twenty":-17.074748,"median":-8.145965,"eighty":-4.836613,"marketCap":2032516879.85},{"date":"2026-05-01","current":-21.708852,"twenty":-17.446705,"median":-8.145965,"eighty":-4.836613,"marketCap":2048664417.22},{"date":"2026-05-08","current":-20.104594,"twenty":-18.289562,"median":-8.145965,"eighty":-4.836613,"marketCap":1897270563.89},{"date":"2026-05-15","current":-20.929048,"twenty":-18.484091,"median":-8.145965,"eighty":-4.836613,"marketCap":1975074256},{"date":"2026-05-22","current":-20.747981,"twenty":-18.597277,"median":-8.145965,"eighty":-4.836613,"marketCap":1957986980.97},{"date":"2026-05-29","current":-21.038179,"twenty":-18.72596,"median":-8.145372,"eighty":-4.83478,"marketCap":1985372996.13},{"date":"2026-06-05","current":-20.100153,"twenty":-18.853618,"median":-8.145965,"eighty":-4.836613,"marketCap":1896851408.78},{"date":"2026-06-12","current":-18.73047,"twenty":-18.92682,"median":-8.147572,"eighty":-4.836613,"marketCap":1767594474.68},{"date":"2026-06-18","current":-19.874645,"twenty":-18.975726,"median":-8.147572,"eighty":-4.836613,"marketCap":1875570245.91},{"date":"2026-06-26","current":-17.909438,"twenty":-19.035823,"median":-8.146769,"eighty":-4.83478,"marketCap":1690113673.98},{"date":"2026-07-02","current":-19.514914,"twenty":-19.171372,"median":-8.146769,"eighty":-4.83478,"marketCap":1841622459.62},{"date":"2026-07-10","current":-21.354702,"twenty":-19.263052,"median":-8.146769,"eighty":-4.83478,"marketCap":2015243222.02},{"date":"2026-07-17","current":-23.499163,"twenty":-19.342456,"median":-8.146769,"eighty":-4.83478,"marketCap":2217616054.05},{"date":"2026-07-24","current":-21.318896,"twenty":-19.450169,"median":-8.146769,"eighty":-4.83478,"marketCap":2011864280.93},{"date":"2026-07-31","current":-19.795385,"twenty":-19.508197,"median":-8.147572,"eighty":-4.832947,"marketCap":1868090447.22},{"date":"2026-08-07","current":-21.609253,"twenty":-19.551097,"median":-8.147572,"eighty":-4.832947,"marketCap":2039265192.74},{"date":"2026-08-14","current":-21.49407,"twenty":-19.589696,"median":-8.147572,"eighty":-4.832947,"marketCap":2028395385.48},{"date":"2026-08-21","current":-23.147418,"twenty":-19.643304,"median":-8.163493,"eighty":-4.832947,"marketCap":2184421878.96},{"date":"2026-08-28","current":-39.962095,"twenty":-19.683215,"median":-8.163493,"eighty":-4.832947,"marketCap":2297820452.45},{"date":"2026-08-31","current":-38.170135,"twenty":-19.694709,"median":-8.163493,"eighty":-4.832947,"marketCap":2194782722.91}],"updateTime":1788271249915},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MESO\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2650390813","title":"Press Release: Ryoncil(r) Delivers Net Revenue of Us$36m for the Fourth Quarter Ended 30 June 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2650390813","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650390813?lang=en_us&edition=fundamental","pubTime":"2026-07-10 08:30","pubTimestamp":1783643400,"startTime":"0","endTime":"0","summary":"NEW YORK, July 09, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced Ryoncil(R) (remestemcel-","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4232","BK7508","MSB","BK7067","BK4006","BK7501","BK4150","MESO","MSC","MSB.AU","BK4139","BK4575","R","BK4022"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650908309","title":"Mesoblast posts US$115m first-year Ryoncil revenue and strengthens capital position","url":"https://stock-news.laohu8.com/highlight/detail?id=2650908309","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650908309?lang=en_us&edition=fundamental","pubTime":"2026-07-10 08:07","pubTimestamp":1783642035,"startTime":"0","endTime":"0","summary":"Mesoblast Limited ( ($AU:MSB) ) has shared an announcement. Mesoblast reported net revenue of US$36 million from Ryoncil in the June quarter, bring...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mesoblast-posts-us115m-first-year-ryoncil-revenue-and-strengthens-capital-position?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mesoblast-posts-us115m-first-year-ryoncil-revenue-and-strengthens-capital-position?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MESO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650970174","title":"Mesoblast Ltd - Ryoncil Q4 Net Revenue of Us$36m and Us$115m for Full Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2650970174","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650970174?lang=en_us&edition=fundamental","pubTime":"2026-07-10 07:58","pubTimestamp":1783641511,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260709:nFWN43B17F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MESO","BK4139","BK7501","BK7067","MSB.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648270045","title":"Analysts Offer Insights on Healthcare Companies: Ligand Pharma (LGND), Mesoblast Limited (OtherMEOBF) and Cogstate Ltd (OtherCOGZF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2648270045","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648270045?lang=en_us&edition=fundamental","pubTime":"2026-07-02 08:40","pubTimestamp":1782952808,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Ligand Pharma (LGND), Mesoblast Limited (MEOBF) and ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-ligand-pharma-lgnd-mesoblast-limited-othermeobf-and-cogstate-ltd-othercogzf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-ligand-pharma-lgnd-mesoblast-limited-othermeobf-and-cogstate-ltd-othercogzf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LGND","LU1559883803.SGD","BK4581","BK4137","HCSG","LU0128526141.USD","LU0566484027.USD","XBI","MEOBF","IE0009354923.USD","BK4585","XLV","BK4588","LU0029874061.USD","BK4139","BK4007","LABU","MESO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648259980","title":"Mesoblast Receives Biologics License Application Filing Number From US FDA; Shares Up 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648259980","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648259980?lang=en_us&edition=fundamental","pubTime":"2026-07-01 10:01","pubTimestamp":1782871305,"startTime":"0","endTime":"0","summary":"Mesoblast  received a biologics license application  filing number from the US Food and Drug Administration  for rexlemestrocel-L in the prevention of gastrointestinal bleeding due to right ventricular dysfunction in end-stage heart failure patients with a left ventricular assist device, according to a Wednesday filing with the Australian bourse.BLA filing number is a six-digit tracking number issued by the FDA to identify and monitor a formal request to market a biologic product.The company also requested a modular review of its BLA for the therapy, the filing said.Shares rose 3% in morning trade on Wednesday.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","BK7067","BK7501","BK4139","MESO","BK4588","BLA.AU","LABU","BK4585","MSB.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648595219","title":"Mesoblast receives BLA filing number from FDA for rexlemestrocel-L review","url":"https://stock-news.laohu8.com/highlight/detail?id=2648595219","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648595219?lang=en_us&edition=fundamental","pubTime":"2026-07-01 08:45","pubTimestamp":1782866714,"startTime":"0","endTime":"0","summary":"Mesoblast (MESO) announced that it has received a Biologics License Application filing number from the U.S. Food and Drug Administration and has re...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mesoblast-receives-bla-filing-number-from-fda-for-rexlemestrocel-l-review-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mesoblast-receives-bla-filing-number-from-fda-for-rexlemestrocel-l-review-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4139","LABU","MESO","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648359593","title":"Mesoblast Receives BLA Filing Number and Requests Modular Review for Rexlemestrocel-L in Patients with End-Stage Heart Failure and LVADs","url":"https://stock-news.laohu8.com/highlight/detail?id=2648359593","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648359593?lang=en_us&edition=fundamental","pubTime":"2026-07-01 08:38","pubTimestamp":1782866280,"startTime":"0","endTime":"0","summary":"NEW YORK, June  30, 2026  (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX:MSB; Nasdaq:MESO), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that it has received a","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/01/3320270/0/en/Mesoblast-Receives-BLA-Filing-Number-and-Requests-Modular-Review-for-Rexlemestrocel-L-in-Patients-with-End-Stage-Heart-Failure-and-LVADs.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4575","LABU","BK4139","BK4006","MSB","BK4585","LU0266512127.USD","IE00BSNM7G36.USD","MESO","LU0122376428.USD","LU0300736062.USD","LU0300736492.USD","LU0170899867.USD","MPC","LU0368265418.SGD","LU0788109394.HKD","LU0266512473.USD","BK4588","LU0456854461.SGD","BK4150","BK4138","MSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648593394","title":"Mesoblast - Requests Modular Review of Bla for Rexlemestrocel-l in End-stage Heart Failure with Lvad","url":"https://stock-news.laohu8.com/highlight/detail?id=2648593394","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648593394?lang=en_us&edition=fundamental","pubTime":"2026-07-01 07:56","pubTimestamp":1782863813,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260630:nFWN4320X2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MSB.AU","BK7501","BK7508","BK7067","BK4139","MESO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648593343","title":"Mesoblast - Rexlemestrocel-l Receives Orphan Drug and Rmat Designations","url":"https://stock-news.laohu8.com/highlight/detail?id=2648593343","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648593343?lang=en_us&edition=fundamental","pubTime":"2026-07-01 07:56","pubTimestamp":1782863813,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260630:nFWN4320X2:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MSB.AU","MESO","BK7067","BK7508","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647584349","title":"JPMorgan exits substantial holder position in Mesoblast","url":"https://stock-news.laohu8.com/highlight/detail?id=2647584349","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647584349?lang=en_us&edition=fundamental","pubTime":"2026-06-29 06:52","pubTimestamp":1782687136,"startTime":"0","endTime":"0","summary":"Mesoblast Limited ( ($AU:MSB) ) has provided an update. JPMorgan Chase & Co. and its affiliates have notified Mesoblast Limited that they have ceas...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/jpmorgan-exits-substantial-holder-position-in-mesoblast?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/jpmorgan-exits-substantial-holder-position-in-mesoblast?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2211815571.USD","IE00BYXW3230.USD","LU1548497426.USD","LU0882574139.USD","BK4207","IE00BKDWB100.SGD","LU0310799852.SGD","LU0211328371.USD","LU2430703251.USD","LU0323591593.USD","IE000M9KFDE8.USD","LU1496350502.SGD","LU0265550946.USD","LU0256863902.USD","JPO","LU0203345920.USD","IE0034235295.USD","LU0238689110.USD","LU1668664300.SGD","LU2237443895.HKD","LU1244550221.USD","JPMO","LU0942090050.USD","JPX","PGF","MESO","LU2023250330.USD","LU0417517546.SGD","BK4581","LU0256863811.USD","LU1670628061.USD","LU2264538146.SGD","LU2756315318.SGD","SG9999002232.USD","LU2054465674.USD","LU0070302665.USD","LU2430703178.SGD","LU2462157665.USD","LU2244417387.USD","IE0034235303.USD","LU1917777945.USD","BK4516","LU1988902786.USD","BK4566","JPM","IE00BZ1G4Q59.USD","LU0640476718.USD","IE00BDRTCR15.USD","LU1261432733.SGD","LU1064131342.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646873514","title":"Mesoblast Accesses $50 Million Credit Line to Refinance Debt Obligations","url":"https://stock-news.laohu8.com/highlight/detail?id=2646873514","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646873514?lang=en_us&edition=fundamental","pubTime":"2026-06-25 16:39","pubTimestamp":1782376755,"startTime":"0","endTime":"0","summary":"Mesoblast  said it has drawn $50 million from a five-year  non-dilutive credit facility provided by shareholder and director Gregory George, strengthening its balance sheet and refinancing higher-cost debt, the company said late Wednesday.The facility carries a fixed 8% annual interest rate and a five-year interest-only term, is secured solely by Temcell royalties, and can be repaid at any time without prepayment penalties or exit fees.Proceeds, together with the company's cash balance, will support growth initiatives while refinancing its NovaQuest debt and eliminating near-term debt obligations, the company said.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MESO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646847745","title":"Mesoblast Draws $50 Million From Facility Provided by Shareholder","url":"https://stock-news.laohu8.com/highlight/detail?id=2646847745","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646847745?lang=en_us&edition=fundamental","pubTime":"2026-06-25 09:02","pubTimestamp":1782349359,"startTime":"0","endTime":"0","summary":"Mesoblast  said it drew down $50 million from a five-year facility provided by Gregory George, a shareholder and director of the company, according to a Thursday filing with the Australian bourse.The credit line carries a fixed interest rate of 8% per year, which marks \"a substantial reduction\" from prior facilities, the company said.Mesoblast had $122 million of cash at the end of March and \"is well funded to invest in its commercial operations and growth pipeline,\" it said.The company's shares fell nearly 2% in recent Thursday trade.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","MSB.AU","BK7067","MESO","BK7501","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646847290","title":"Press Release: Mesoblast Draws US$50 Million from Five-year Non-dilutive Facility","url":"https://stock-news.laohu8.com/highlight/detail?id=2646847290","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646847290?lang=en_us&edition=fundamental","pubTime":"2026-06-25 08:59","pubTimestamp":1782349140,"startTime":"0","endTime":"0","summary":"Optimized capital structure, retiring short-term maturing debtWell-funded for commercial operations and growth pipelineNEW YORK, June 24, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:M","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4150","BK4006","BK7067","BK4575","MSC","BK4022","MSB.AU","BK7501","MSB","BK4139","BK4232","BK7508","MESO","R"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646784205","title":"Mesoblast Taps US$50m Low-Cost Facility to Retire High-Cost Debt and Fund Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2646784205","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646784205?lang=en_us&edition=fundamental","pubTime":"2026-06-25 08:08","pubTimestamp":1782346127,"startTime":"0","endTime":"0","summary":"Mesoblast Limited ( ($AU:MSB) ) has provided an update. Mesoblast has secured US$50 million from a five-year, non-dilutive credit facility provided...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mesoblast-taps-us50m-low-cost-facility-to-retire-high-cost-debt-and-fund-growth?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mesoblast-taps-us50m-low-cost-facility-to-retire-high-cost-debt-and-fund-growth?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MESO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642259232","title":"Mesoblast Says JPMorgan Ceases to be Substantial Holder","url":"https://stock-news.laohu8.com/highlight/detail?id=2642259232","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642259232?lang=en_us&edition=fundamental","pubTime":"2026-06-12 11:38","pubTimestamp":1781235489,"startTime":"0","endTime":"0","summary":"Mesoblast (ASX:MSB) said JPMorgan Chase and its affiliates ceased to be substantial holders of the firm on Tuesday, according to a Friday Australian bourse filing.Its shares rose 1% in recent trading on Friday.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0345770993.USD","JPM","LU1119994496.HKD","IE00BDCRKT87.USD","LU1974910355.USD","LU2211815571.USD","LU2552382215.SGD","JPX","LU0859254822.USD","LU1244550221.USD","LU0868494708.USD","LU2357305700.SGD","LU0976567544.SGD","LU1668664300.SGD","LU2237443895.HKD","LU2430703251.USD","LU1670627923.USD","LU2023250504.SGD","LU2462157665.USD","LU0256863902.USD","LU1551013342.USD","IE00BFXG1179.USD","LU1162221912.USD","JPMO","LU1116320737.USD","LU1894683348.USD","LU2237443622.USD","LU2237443549.SGD","LU2237443465.HKD","MSB.AU","LU0211326755.USD","PGF","IE0034235295.USD","LU0211331839.USD","LU1670628061.USD","LU0417517546.SGD","LU0211326839.USD","IE00BBT3K403.USD","LU1914381329.SGD","SG9999002232.USD","BK4139","LU0048584097.USD","LU1261432733.SGD","LU2213496289.HKD","LU2430703095.HKD","IE00BKDWB100.SGD","MESO","JPO","IE00BLSP4452.SGD","BK4550"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642142926","title":"Mesoblast Showcases Profitable Ryoncil Launch and Expanding Cell Therapy Pipeline in June 2026 CEO Presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=2642142926","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642142926?lang=en_us&edition=fundamental","pubTime":"2026-06-10 21:16","pubTimestamp":1781097378,"startTime":"0","endTime":"0","summary":"The latest update is out from Mesoblast ( ($MESO) ). On June 2, 2026, Mesoblast lodged an ASX CEO Connect presentation highlighting that its first ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mesoblast-showcases-profitable-ryoncil-launch-and-expanding-cell-therapy-pipeline-in-june-2026-ceo-presentation?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mesoblast-showcases-profitable-ryoncil-launch-and-expanding-cell-therapy-pipeline-in-june-2026-ceo-presentation?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MESO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631759508","title":"Mesoblast Says Nearly $100 Million in Revenue Generated During First Year of Ryoncil Launch; Shares Fall 5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631759508","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631759508?lang=en_us&edition=fundamental","pubTime":"2026-04-30 12:02","pubTimestamp":1777521749,"startTime":"0","endTime":"0","summary":"Mesoblast  said gross sales for Ryoncil, its mesenchymal stromal cell product, during the March quarter were $35.3 million, according to a Thursday Australian bourse filing.Net revenue was $30.3 million, bringing the revenue generated during the first year of the product's launch to nearly $100 million, per the filing.Receipts from customers were $34.6 million in the March quarter, compared with $1.5 million in the year-ago period.Mesoblast's shares fell nearly 5% in recent trading on Thursday.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MESO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631796005","title":"Press Release: Mesoblast Reports Ryoncil(R) Net Revenues of US$30.3m and Improved Net Operating Cash Spend for the Quarter to US$4.1 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2631796005","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631796005?lang=en_us&edition=fundamental","pubTime":"2026-04-30 08:55","pubTimestamp":1777510500,"startTime":"0","endTime":"0","summary":"Achieved Patient Recruitment Target in Pivotal Phase 3 Trial for Chronic Low Back Pain. Activity Report for Quarter Ended March 31, 2026 . NEW YORK, April 29, 2026  -- Mesoblast Limited , global leader in allogeneic cellular medicines for inflammatory diseases, today provided highlights of its recent activities for the third fiscal quarter ended March 31, 2026.\"We've had a busy and exciting March quarter marked by a series of major achievements. Ryoncil revenues are now approaching US$100 million since last year's launch, we have substantially improved our net operating cash spend, our pivotal trial in inflammatory back pain has successfully achieved its patient recruitment target, and we have bolstered our long-term leadership in the field by acquiring genetically modified technology for precision-enhanced cell therapy products,\" said Dr. Silviu Itescu, Mesoblast Chief Executive.FINANCIAL HIGHLIGHTS FOR QUARTER ENDED MARCH 31, 2026. -- Ryoncil gross sales for the quarter were US$35.3 ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MESO","R"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631555111","title":"Mesoblast Achieves Patient Recruitment Target in Pivotal Phase 3 Trial for Chronic Low Back Pain","url":"https://stock-news.laohu8.com/highlight/detail?id=2631555111","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631555111?lang=en_us&edition=fundamental","pubTime":"2026-04-29 08:53","pubTimestamp":1777423980,"startTime":"0","endTime":"0","summary":"NEW YORK, April  28, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that its pivotal Phase","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/29/3283366/0/en/Mesoblast-Achieves-Patient-Recruitment-Target-in-Pivotal-Phase-3-Trial-for-Chronic-Low-Back-Pain.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MSB","BK4139","BK4161","DDD","MSC","BK4546","BK4150","BK4170","BK4585","BK4006","MESO","BK4588","BK4551","BK4575"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631555686","title":"Mesoblast Hits Phase 3 Recruitment Milestone in Chronic Back Pain Push","url":"https://stock-news.laohu8.com/highlight/detail?id=2631555686","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631555686?lang=en_us&edition=fundamental","pubTime":"2026-04-29 08:44","pubTimestamp":1777423461,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Mesoblast Limited ( ($AU:MSB) ). Mesoblast has reached its patient recruitment target for a pivotal Phase 3 tri...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mesoblast-hits-phase-3-recruitment-milestone-in-chronic-back-pain-push?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mesoblast-hits-phase-3-recruitment-milestone-in-chronic-back-pain-push?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MESO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":3,"totalSize":96,"code":"91000000","status":"200"}]}}